Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus
- 31 August 2006
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 18 (4) , 224-229
- https://doi.org/10.1016/j.smim.2006.03.010
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Corporation
- Ministry of Health, Labour and Welfare
This publication has 68 references indexed in Scilit:
- Paths to understanding the genetic basis of autoimmune diseaseNature, 2005
- Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral InfectionJournal of Biological Chemistry, 2004
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humansNature Genetics, 2002
- CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter regionHuman Genetics, 2002
- Review: On the Role of IRF in Host DefenseJournal of Interferon & Cytokine Research, 2002
- Fine Mapping of the SLEB2 Locus Involved in Susceptibility to Systemic Lupus ErythematosusGenomics, 2000
- A Susceptibility Locus for Human Systemic Lupus Erythematosus (hSLE1) on Chromosome 2qJournal of Autoimmunity, 2000
- The combination of polymorphisms within interferon‐γ receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosusFEBS Letters, 1999
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979